Cefazolin sodium contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Cefazolin sodium}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Contraindications== | ==Contraindications== | ||
Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate hypersensitivity reactions (e.g., anaphylaxis, serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactams [see Warnings and Precautions (5.1)].<ref>{{Cite web | last = |first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf |publisher =|date = | accessdate = }}</ref> | |||
Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate [[hypersensitivity]] reactions (e.g., [[anaphylaxis]], serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, [[penicillins]] or other beta-lactams [see Warnings and Precautions (5.1)].<ref>{{Cite web | last = |first =|title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf |publisher =|date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 00:43, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
Cefazolin for Injection, USP is contraindicated in patients who have a history of immediate hypersensitivity reactions (e.g., anaphylaxis, serious skin reactions) to cefazolin or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactams [see Warnings and Precautions (5.1)].[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50461slr139_ancef_lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.